RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Combination Full-Dose IV-tPA + Argatroban is Safe and May Result in Higher Rates of Recanalization
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 1
SP 17
OP 18
DO 10.1177/155989771101011
UL http://mdc.sagepub.com/content/11/1/17.2.abstract
AB Argatroban is a direct thrombin inhibitor that safely augments the benefit of tPA in animal stroke models; however, human data are limited. The Argatroban tPA Stroke Study [ARTSS; NCT00268762] is a multicenter, Phase II, prospective, open-label, safety and activity study of argatroban and tPA in patients with ischemic stroke.